ADDvise Group

Media, investors and analysts are invited to attend a presentation of the interim report for the period July 1 – September 30, 2024. The presentation will take place on October 24, 2024, at 14:00 (CEST) / 08:00 AM (EST).

CEO, Staffan Torstensson, and Interim CFO, Johan Irwe, will present the report in a webcast and telephone conference.

Webcast

If you wish to participate via webcast, please use the link below.

https://ir.financialhearings.com/addvise-group-q3-report-2024

Conference call

If you wish to participate via teleconference, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference.

https://conference.financialhearings.com/teleconference/?id=50048646

The report, presentation material and a link to the webcast will be available on
https://www.addvisegroup.com/investor-relations/

For further information, please contact:
Staffan Torstensson, CEO
+46 70 433 20 19
staffan.torstensson@addvisegroup.se

About ADDvise Group
ADDvise is an international life science group. Operating a decentralised ownership model, we develop and acquire high quality companies within the business areas Lab and Healthcare. The Group comprises more than 20 companies and generates annual revenues of close to SEK 2 billion. ADDvise is listed on Nasdaq First North Premier Growth Market. Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the company's Certified Adviser. More information is available at www.addvisegroup.com.